Literature DB >> 24964703

Social and ethical analysis in health technology assessment.

Sripen Tantivess.   

Abstract

This paper presents a review of the domestic and international literature on the assessment of the social and ethical implications of health technologies. It gives an overview of the key concepts, principles, and approaches that should be taken into account when conducting a social and ethical analysis within health technology assessment (HTA). Although there is growing consensus among healthcare experts that the social and ethical ramifications of a given technology should be examined before its adoption, the demand for this kind of analysis among policy-makers around the world, including in Thailand, has so far been lacking. Currently decision-makers mainly base technology adoption decisions using evidence on clinical effectiveness, value for money, and budget impact, while social and ethical aspects have been neglected. Despite the recognized importance of considering equity, justice, and social issues when making decisions regarding health resource allocation, the absence of internationally-accepted principles and methodologies, among other factors, hinders research in these areas. Given that developing internationally agreed standards takes time, it has been recommended that priority be given to defining processes that are justifiable, transparent, and contestable. A discussion of the current situation in Thailand concerning social and ethical analysis of health technologies is also presented.

Mesh:

Year:  2014        PMID: 24964703

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  2 in total

1.  Evidence-Based Decision Making 3: Health Technology Assessment.

Authors:  Daria O'Reilly; Richard Audas; Kaitryn Campbell; Meredith Vanstone; James M Bowen; Lisa Schwartz; Nazila Assasi; Ron Goeree
Journal:  Methods Mol Biol       Date:  2021

2.  Q-SEA - a tool for quality assessment of ethics analyses conducted as part of health technology assessments.

Authors:  Anna Mae Scott; Björn Hofmann; Iñaki Gutiérrez-Ibarluzea; Kristin Bakke Lysdahl; Lars Sandman; Yvonne Bombard
Journal:  GMS Health Technol Assess       Date:  2017-03-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.